A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer (Q39945156)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer |
scientific article |
Statements
1 reference
A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer (English)
1 reference
Kaisa Leea Sunela
1 reference
Sanna Koskinen
1 reference
Pirkko-Liisa Kellokumpu-Lehtinen
1 reference
22 September 2009
1 reference
1 reference
Identifiers
1 reference